The Bacillus subtilis levanase structural gene sacC was expressed under the regulated control of sacR, the inducible levansucrase leader region, in a degU32(Hy) strain. In this genetic context, exocellular levanase is overproduced (0.5 O/ O of total protein) during the exponential phase of growth upon induction by sucrose a t 37 "C and pH 7. No precursor form that comprised a signal peptide was detected in pulse-chase experiments. The subsequent release of the cell-associated processed protein is a slow event (tl,2 = 802 10 5). The unfolding-folding transition of pure levanase monitored in vitro by the resistance to proteolysis was achieved within the same time range (tln = 50 s) under the same conditions of pH and temperature. Calcium ions, which modulate the rate and the yield of refolding, have a low affinity for the protein.
INTRODUCTION
Keywords : levanase, protein secretion, late stage of secretion, folding, Bacillus subtilis -We have recently shown (Leloup et al., 1997) that the expression of the structural gene amyE under the control of the inducible levansucrase leader region sacR in a degU32(Hy) strain leads to an overproduction of aamylase. Such a context was suitable for the characterization in vivo of the sequential events of the secretion process of a-amylase.
Comparison of the levansucrase and a-amylase secretion mechanisms drew our attention to the fact that cleavage of the a-amylase signal peptide was more rapid than that of levansucrase (Petit-Glatron et al., 1987; Leloup et a/., 1997) . Nevertheless, for both proteins, the final stage of mature protein release is slow, t I i z = 60 s and 120 s for levmsucrase and a-amylase, respectively, and is seemingly coupled with the folding.
The efficiency of the membrane translocation process could therefore be specific to each exoprotein family,
-_ _ such as proteins produced and secreted during the exponential phase (levansucrase) or the stationary phase (levanase or a-amylase), whereas the mechanism underlying the final release could be common. In the present work, we examined the levanase SacC secretion pathway to test the validity of this general outline. We chose this protein for the following reasons. (i) Its signal sequence region (Schorgendorfer et al., 1987) displays, like aamylase, a hydrophobicity twice that of levansucrase (Scotti et al., 1996) . Is this feature therefore correlated with the efficiency of the translocation mechanism? (ii) This protein has a higher molecular mass, 73 kDa, than levansucrase (50 kDa). Does such a difference affect the rate of release, which includes the passage through the cell wall, or does this rate only correlate with the folding kinetics of the protein? The answers to these questions could provide new information about each stage of the general mechanism of secretion we propose (Petit- the stationary phase of growth in the wild-type strain 168 Marburg (Fuchs, 1959) , and degU32(Hy) mutations inducing overproduction of several exocellular enzymes do not cause overproduction of levanase (Kunst et d., 1977) .
Characterization in vivo of the sequential events that lead up to secretion of levanase is not possible by conventional biochemical methods in this context of low production. We therefore placed sacC under the regulated control of sacR, the levansucrase leader region, in a degU32(Hy) strain. Under these conditions levanase is overproduced and it is then possible to compare its secretion with that of a-amylase and levansucrase in the same genetic context and under the same growth conditions.
METHODS
Strains and media. The Bacillus subtilis strain GM96201 contained a sad-sucC fusion which was introduced into the chromosome of strain GM96100, as previously described (Leloup et al., 1997) . Bacteria were grown at 37 "C in minimid medium (Chambert & Petit-Glatron, 1984) supplemented with 1 O/O (w/v) glucose and 0.5 m M CaCl,. Strains and plasmids are listed in Table 1 .
Plasmid and DNA manipulation. The DNA fragments carrying sac, the levanase structural gene including its signal sequence, or SUCR, the sacB (levansucrase structural gene) leader region, were amplified by PCR (Petit-Glatron & Chambert, 1992) with the chromosomal DNA of strain Q B l l 2 or pLS50 (Steinmetz et al., 1985) as templates and A and B or C and D oligonucleotides for sacC and sacR, respectively : A, 5" AAGGAGACGTCAACGATG 3' (forward primer), and B, 5' AAAGGCCTGCAGAACACCTGATGATTTGG 3' (reverse primer), with AatII and StuI sites (shown in bold) in A and B, respectively; C, 5' CGCGGATCCTTTTTAACCCATCAC-~~ ATATACCTG 3' (forward primer), and D, 5' CATCGTT-GACGTCTCCTT 3' (reverse primer), with BamHI and AatII sites (in bold) at the 5' end of C and D, respectively. The restriction sites were included in the primers to facilitate subsequent in-frame fusion of the regulatory region and the coding sequence, and insertion into the appropriate vector. The amplified fragments were purified by electroelution after electrophoresis on an agarose gel. The fragments were then blunted by Pfu DNA polymerase treatment and inserted into the Srfl site of the pCR( + ) vector according to the supplier's recommendations (Stratagene), resulting in plasmids pGMC9 and pGMC10. The BarnHI-AatII fragment (sacR) of pGMC9 was purified and ligated into pGMClO (containing the sacC fragment) digested with the same endonucleases. The resulting plasmid was used to transform Escherichia coli TG1. In these plasmids, which were purified from E. coli transformants and exhibited fragments of the expected size after digestion by various endonucleases, we verified the in-frame fusion between the two DNA fragments by sequencing the amplified fragments, using the Sequenase kit (USB) and double-stranded plasmid DNA. . One unit of enzyme activity was defined as the amount of enzyme that releases one pmol fructose min-' in the presence of 10 mg labelled levan ml-l (which corresponds to 0.06 M fructosyl unit). One enzyme unit corresponds to 8.5 pg pure levanase. forms of levanase were analysed by immunoblotting as described previously (Petit-Glatron et al., 1987) .
Pulse-chase experiment. Under the usual conditions of growth, B. subtilis cells were induced with sucrose (60 m M final concentration) and pulse-labelled at an ODGo0 of 2 by adding 0.25 mCi (9 MBq) ["*'S]methionine (800 Ci mmol-l) to 1 ml culture suspension maintained at 37 "C. After a pulse period of 30 s, non-radioactive methionine (4 mM final concentration) was added. Samples of 0.2 ml were withdrawn at intervals and all reactions were immediately stopped by diluting the samples threefold with ice-cold stopping buffer (0.1 M sodium phosphate, pH 7, containing 2.4 M KCl, 200 pg chlorarnphenicol ml-l and 0.2 mM PMSF). Cell suspensions were centrifuged and the supernatants were dialysed overnight at 4 "C: against TNE buffer (50 m M Tris/HCl, pH 8, containing 1.50 mM NaCl and 5 mM EDTA) and diluted fivefold in T N E T (TNE buffer containing 1 %, v/v, Triton X-100). The bacterial pellets were washed with ice-cold stopping buffer without KCI, resuspended in 0.3 ml TNES (TNE buffer Containing 2 ' / o , w/v, SDS) and diluted fivefold in TNET. Cells were disrupted by sonication. The suspensions were incubated for 5 min at 95 "C. Antibodies against B. subtilis levanase (20 pl) and 10% (w/v) Protein-A-Sepharose (80 pl) (Sigma) in TNET were then added to 0.3 ml dialysed supernatants and to the disrupted cells. After overnight incubation at 4 "C, the immunoprecipitates were recovered by centrifugation. The pellets were washed three times with 1 ml T N E T and finally resuspended in electrophoresis sample buffer. The samples were hoiled for 3 min and analysed by SDS-PAGE.
Purification of levanase. Exocellular levanase was purified from the supernatant of strain GM96201 harvested at the end of the exponential phase of growth. Supernatant was first concentrated 20-fold on a bioconcentrator miniplate (Millipore), then the enzyme was obtained in a pure state after the successive chromatographic steps, as follows.
Step 1 : hydroxylapatite (HA) chromatography. The supernatant, concentrated from 3 1 culture, was loaded on a HA column (15 x 1 cm) pre-equilibrated with 0.1 M sodium phosphate, pH 6.5.
The column was washed with the same buffer, and proteins were eluted with a linear gradient of sodium phosphate from 0.1 to 0-8 M. Levanase activity was eluted by 0.5 M phosphate. Fractions containing activity were pooled, dialysed against 0-1 M sodium phosphate, pH 6.5, and re-concentrated up to 2 ml with vivaspin (Vivascience).
Step 2 : gel-filtration chromatography. We ran gel-filtration Chromatography using a 70 x 2.5 cm Biogel P150 column (200-400 mesh; Bio-Rad) with continuous elution at a constant rate of 45 ml h-' at 5 "C with 0.1 M sodium phosphate, pH 6. Fractions containing levanase activity were pooled and dialysed against 0.01 M sodium phosphate, pH 7.
Step 3 : DEAE-Sepharose chromatography. The dialysed protein solution was loaded on a DEAE-Sepharose anion-exchange colum~i (20 x 1 cm) pre-equilibrated with 0.01 M sodium phosphate, pH 7. The column was washed with the same buffer and proteins were eluted with a linear gradient of 0-0.6 M NaCI. Levanase activity was eluted by 0.4 M NaCl.
Purified levanase migrated as a single protein band on 10% (w/v) SDS-PAGE and had an apparent molecular mass of 73000 Da.
Antibodies against levanase. Antibodies raised in rabbits were prepared against pure levanase.
RESULTS

Construction of strain GM96201 overproducing levanase during the exponential phase of growth
The BamHI-StuI fragment of pGMCll carrying the fusion of PsacB to the sacC structural gene w a s ligated between the BamHIIEcoRV sites in pGMK.50 (PetitGlatron & Chambert, 1992) to give pGMK64, a n integrative plasmid in which the sacC gene is under the control of the sacB leader region. pGMK64 was integrated by a Campbell-like mechanism into the chromosome of GM96100 (Leloup et al., 1997) . The transformants were selected from LB plates containing the appropriate antibiotic. We confirmed the presence of the sacR-sacC fusion in the transformants by PCR using appropriate oligonucleotides. One of the transformants containing the P,,,,-sacC fusion and exhibiting sucroseinducible expression of levanase was chosen for further analysis and named GM96201.
When strain GM96201 was grown in the absence of sucrose, no levanase activity (Fig. l a ) or labelled levanase (pulse experiment, not shown) was detected in the supernatant. In the presence of sucrose, production of exolevanase occurred at a constant differential rate of synthesis, 5 pg mg-', during the exponential phase of growth. Pulse experiments (Fig. l b ) showed that levanase is one of the major proteins released into the growth medium. The molecular mass of secreted levanase is 73 kDa as expected from the nucleotide sequence of the structural gene sacC (Schorgendorfer et al., 1987) . We observed that the production of exocellular levanase is around ten times lower than that of levansucrase in the parent strain Q B l l 2 (Chambert & Petit-Glatron, 1984) . This point will be discussed later. subtilis levanase measured by resistance to proteolysis a t 37 "C, 0.1 M sodium phosphate, a t pH 7. Unfolding was promoted (arrow 1) b mixing 20 pI stock solution of purified levanase withdrawn a t the times indicated and quickly mixed with 92 pl 0.1 M sodium phosphate, pH 7, containing 10 pg subtilisin ml-'. Refolding was initiated (arrow 2) after 30 min unfolding by mixing 40 pl unfolding mixture with 460 pl 0.1 M sodium phosphate, pH 7, containing 0.5 mM calcium. Samples (100 PI) were withdrawn a t the times indicated and quickly mixed with 2 pI of a 0.5 mg subtilisin ml-' solution, and incubated for 5 min. PMSF was then added to the samples. Aliquots (80 PI) of all the samples were subjected to SDS-PAGE. Aliquots (5 pl) were analysed for levanase activity. (0) and from measurements of the residual enzyme activity (a).
(1.5 mg ml-Y ) with 150 pl 10 M urea, pH 7. Samples (8 pl) were
Sequential stages of the levanase secretion process
We characterized the discrete stages of the levanase secretion pathway from pulse-chase experiments (Fig.  2) . We did not detect any unprocessed precursor of levanase whose expected molecular mass is 76 kDa (deduced from the nucleotide sequence). However, a cell-associated form with the same molecular mass as the exocellular protein (73 kDa) disappeared slowly from the cells and was concomitantly released into the culture supernatant. The tl,2 of this event was evaluated 
Fig. 4.
Unfolding-refolding transition of levanase mediated by Ca2+ a t 37 "C, pH 7. Stock solution (15 PI) of purified protein (1.5 mg ml-') was preincubated for 30 min in 105 pl 10 M urea in 0.1 M sodium acetate a t pH 7. Refolding was initiated by mixing 60 pl of the unfolding mixture with 700 pl 0-1 M sodium acetate, pH 7, containing or not 20 mM calcium chloride. Samples (90 pl) were withdrawn a t the time indicated and quickly mixed with 2 pl 1 mg subtilisin ml-I solution. Samples were submitted to SDS-PAGE analysis, and were assayed for levanase activity. (Leloup et al., 1997) when these proteins were overproduced. We pointed out that the time constant of the processed precursor release of these two proteins was of the same order of magnitude as the time constants of in r d r o refolding of the proteins occurring under the same conditions of pH, temperature and ionic strength. We tested whether a similar correlation could be observed with levanase.
Kinetics of unfolding-refolding of levanase in vitro: calcium is a modulator of the folding reaction
The unfolding-folding transition was measured by monitoring the appearance and disappearance of the subtilisin sensitivity of the protein (Fig. 3) . In the presence of 8.75 M urea, at p H 7 and 37 "C, unfolding occurred with a tllz of 7 1 min. After dilution of the denaturing agent in 0.1 M sodium phosphate, p H 7, at 37 OC, the unfolding-folding transition occurred with a high yield ( Y = SO0%) and the t l l z of the reaction was 4 6 + 5 s. The rate of levanase refolding is therefore approximately the same as that of in uiuo release of the protein under the same conditions of pH, temperature and ionic strength. Similar observations have been made for levansucrase (Chambert et al., 1995) and a-amylase (Leloup et al., 1997) . We proposed that the release and folding processes are coupled on the external side of the cytoplasmic membrane. Moreover, we identified the calcium ion as being a folding modulator that can assist such a coupling . In the case of levanase, we observed that the presence of calcium increases the rate and yield of refolding (Fig. 4) . We examined the ability of levanase to bind calcium in comparison to other secreted proteins by the method of Maruyama et al. (1984) using a dot blot assay with pure proteins (Fig. 5) . The radioactive spots were quantified by phosphor-imaging. The ability of levanase to bind calcium was approximately the same as that of levansucrase. Therefore, we can reasonably conclude that levanase, a-amylase and levansucrase have some common folding properties : calcium increased the rate of refolding of each protein; however, the affinities of the native proteins to calcium are very low. The folding catalyst effect of calcium could play an important role in the final stage of their secretion processes.
DISCUSSION
The expression of sacC under the control of the leader region of levansucrase led to an overproduction of exocellular levanase during the exponential phase of growth of B. subtilis. Pulse-chase experiments showed some differences in the timing of the cellular sequential events leading to secretion compared with those of levansucrase. In contrast to levansucrase, we observed no unprocessed intermediates in the sequential process of levanase secretion, suggesting that the precursor processing is very rapid. The same result was obtained (b) were equilibrated for 15 min a t room temperature in 0.1 M potassium acetate or 0.1 M potassium phosphate, pH 7, respectively. Then each piece of membrane was incubated for 1 h in 1 ml of the same buffer containing 10 pCi (370 kBq) 45CaCI,. After 20 min washing in a large volume of buffer, the membranes were dried, exposed to a Kodak X-Omat film and quantified by phosphor-imaging (c). Open bars, calcium binding shown in (a); striped bars, that shown in (b). 1 and 3, ovalbumin and bovalbumin used as controls of non calcium-binding proteins; 2, a-amylase of Bacillus licheniformis; 4, levansucrase; 5, a-amylase of B. subtilis; 6, levanase; 7, a-amylase of Bacillus amyloliquefaciens.
when a-amylase was expressed in the same genetic and physiological context (Leloup et al., 1997) . Since these three proteins are all native exocellular proteins of B. subtilis, these intriguing results led us to assume that the rate of the leader peptide cleavage depends on features that are intrinsic to this peptide. Alternatively, the efficiency of the initial step of secretion, i.e. the entry into the export pathway via its association with SecA (den Blaauwen & Driessen, 1996) , is different and specific to each leader peptide. The signal sequence of levansucrase is very different to that of levanase and aamylase. The h-domain of these two latter proteins is 1.5 times longer than that of levansucrase and their overall hydrophobicity is much greater. Furthermore, the net charge of the first amino acids immediately downstream from the signal sequence is negative for a-amylase and Ievanase and positive for levansucrase. Further experiments dealing with exchange of leader peptides between these proteins should provide new insights into these issues.
The most exciting result obtained in this work concerns the kinetic characterization of the ultimate stage of the secretion process, i.e. the release of the processed protein. Levanase is the third model protein for which we have observed that the half-life of such an event is similar to the half-life of in vitro refolding of the protein occurring under the same conditions of pH, temperature and ionic strength. Furthermore, these two events occur within the same time range (tl,2 = 1-2 min) for the three proteins despite their large molecular mass difference. These results suggest that the rate of the release stage, which includes the crossing of the cell wall, is not dependent on protein size as it was previously postulated (Demchick & Koch, 1996) , but rather dependent on their folding rate. The final point of interest concerns the difference in the levels of synthesis of levanase and levansucrase even though the two structural genes were under the same transcriptional control. Levanase synthesis is ten times lower than that of levansucrase. Similar results have been reported for a-amylase, whose level of synthesis is about five times lower (Leloup et al., 1997) , and also for other heterologous model proteins expressed under the regulatable control of the levansucrase leader region (Simonen & Palva, 1993) .
For the expression of heterologous proteins this difference was generally explained by post-transcriptional events such as the inability of the secretory apparatus to recognize foreign proteins, the protease sensitivity of these proteins or competition for the secretion apparatus.
We have demonstrated unambiguously that, for the expression of homologous a-amylase and levanase, none of these explanations applies because the proteins adopt in vitro a proteolytically insensitive structure at approximately the same rate as levansucrase and their levels of production remain the same in strains deleted or not for the levansucrase structural gene. Presumably the difference in the production level is mostly due to differences in transcription or translational efficiency. Preliminary experiments have indicated that the level of a-amylase and levanase mRNAs in fully induced strains correlates with respective protein production. This disparity may be due to differences in mRNA stability or to other factors as yet unknown. A difference in codon usage could also affect the rate of mRNA translation depending on the phase of production of the different genes (Steinmetz et al., 1985; Shields & Sharp, 1987) .
